Delivery Order 75N91019D00024-75N91026F00028
Award Date 9/30/26
Potential Completion Date 10/25/28
Potential Value $1.9M
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 2, 2016, with a ceiling value of $18.5 million for Building 538, 1st Floor refurbishment and infrastructure at the Frederick National Laboratory for Cancer Research. Place of performance is Frederick, MD. The order carries a cost-no-fee pricing structure and an ultimate completion date of June 30, 2019. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 9, 2026, with a ceiling value of $1,511,990 for roof replacements at its Frederick, Maryland facility (Buildings B539 & 560). The order is priced on a cost-plus-fixed-fee basis and is scheduled for ultimate completion by May 5, 2028. Leidos Biomedical Research Inc. operates the Frederick National Laboratory for Cancer Research as an FFRDC contractor under a master indefinite delivery vehicle...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 26, 2015, with a ceiling value of $7.66 million for Building 538 infrastructure project work at the Frederick National Laboratory for Cancer Research. The delivery order is priced on a cost-no-fee basis with an ultimate completion date of June 30, 2019. Place of performance is Frederick, Maryland. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center...
- The National Cancer Institute issued a $652,353 delivery order to Leidos Biomedical Research Inc. on July 30, 2026, for replacement of Building 1023 Rooms 8 and 9 at the Frederick National Laboratory for Cancer Research, with ultimate completion by November 15, 2027. The order is priced on a cost-plus-fixed-fee basis. Place of performance is Frederick, MD. Leidos Biomedical Research operates the Frederick National Laboratory as an FFRDC contractor and holds master indefinite delivery vehicles...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 8, 2026, with a ceiling value of $1,291,828 for replacement of chiller #3 at the Frederick National Laboratory for Cancer Research. This delivery order is issued under a cost-plus-fixed-fee pricing structure against Leidos Biomedical Research's master FFRDC indefinite delivery contract with NCI. Place of performance is Frederick, MD 21702. The ultimate completion date is May 3, 2028. The work...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 15, 2016, with a ceiling value of $4,527,878.03 for Building 433 North refurbishment and infrastructure work, with final funding modification (MOD 010) completing the order on September 6, 2019. Place of performance is Frederick, Maryland. The delivery order is priced on a cost-no-fee basis. Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., operates as a Federally Funded...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 15, 2017, for refurbishment and infrastructure upgrades to Building 539, 1st Floor, Phase 1, with a ceiling value of $7.16 million under cost-plus-fixed-fee pricing. Place of performance is Frederick, MD. The ultimate completion date is September 30, 2020. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor serving the National Cancer...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 4, 2025, for miscellaneous safety upgrades at the Frederick National Laboratory for Cancer Research, with a ceiling value of $1.676 million under a cost-plus-fixed-fee pricing structure. Place of performance is Frederick, Maryland. The order extends through June 30, 2028. Leidos Biomedical Research, a subsidiary of Leidos Holdings Inc. and an FFRDC contractor, operates the Frederick National...
- The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 12, 2016, with a ceiling value of $13.3 million for Building 469 second-floor refurbishment and infrastructure work at the Frederick National Laboratory for Cancer Research. The order was issued under cost-no-fee pricing and reached ultimate completion on July 9, 2021. Place of performance is Frederick, MD. The work encompassed building renovation and infrastructure improvements supporting NCI's...
- The National Cancer Institute issued a $2,034,923 delivery order to Leidos Biomedical Research Inc. on September 17, 2025, with an ultimate completion date of September 30, 2027, under a cost-plus-fixed-fee pricing structure. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor subsidiary of Leidos Holdings, Inc., providing biomedical research and facilities support services to the National Cancer Institute and National Institutes of Health....